Cancer News and Research

Latest Cancer News and Research

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

Nanobiotix, a company developing novel cancer nanotherapeutics, announced today that its lead compound NBTXR3 has received the formal authorization from the French Medicine Agency, AFSSAPS, to start the first clinical trial.

14 Sep 2011

University of Antioquia and IBM partner for Leishmaniasis research

IBM and University of Antioquia's Tropical Disease Study and Control Program (PECET) today announced a joint research project, Drug Search for Leishmaniasis, using computer power from IBM's World Community Grid.

14 Sep 2011

Web-based tool can improve employment outcomes of breast cancer survivors

In a paper to be presented at the upcoming HFES 55th Annual Meeting in Las Vegas, Nevada, human factors/ergonomics researchers will describe WISE, a Web-based tool for breast cancer survivors designed to reduce work disabilities and improve employment outcomes.

14 Sep 2011

Curcumin suppresses cell signaling pathway that drives growth of head and neck cancer

Curcumin, the main component in the spice turmeric, suppresses a cell signaling pathway that drives the growth of head and neck cancer, according to a pilot study using human saliva by researchers at UCLA's Jonsson Comprehensive Cancer Center.

14 Sep 2011

Lignans lower risk of death in women with breast cancer

Phytoestrogens are plant compounds which, in the human body, can attach to the receptors for the female sexual hormone estrogen and which are taken in with our daily diet. A number of findings have attributed a cancer protective effect to these plant hormones. At DKFZ, a team headed by Prof. Dr. Jenny Chang-Claude summarized the results of several studies in a meta-analysis last year and showed that a diet rich in phytoestrogens lowers the risk of developing breast cancer after menopause.

14 Sep 2011

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

Families with children suffering from brain tumours caused by an uncommon genetic disorder known as Tuberous Sclerosis Complex (TSC) have new hope with Health Canada's recent conditional approval of a new therapeutic use for the drug Afinitor (everolimus). Afinitor is the first drug therapy approved in Canada for the treatment of brain tumours caused by TSC in patients three years of age and older.

14 Sep 2011

Roundup: N.J. Governor opts not to cut Medicaid rolls; Seattle council mandates sick leave

Thousands of New Jersey's working poor will keep their health insurance under a new administration proposal to restructure Medicaid, abandoning a controversial plan that would have drastically reduced the number of eligible recipients.

14 Sep 2011

Intrauterine devices may lower risk of cervical cancer among users, study shows

Contraceptive intrauterine devices (IUDs), also called coils, "might actually protect women against developing cervical cancer even though they don't stop the infection that commonly leads to the disease," according to a study published Tuesday in the journal Lancet Oncology, Reuters reports.

14 Sep 2011

Spices boost broccoli's power to fight cancer

Teaming fresh broccoli with a spicy food that contains the enzyme myrosinase significantly enhances each food's individual cancer-fighting power and ensures that absorption takes place in the upper part of the digestive system where you'll get the maximum health benefit, suggests a new University of Illinois study.

14 Sep 2011

Tengion reinitiates enrollment in Neo-Urinary Conduit clinical trial for bladder cancer

Tengion, Inc. today announced that it has reinitiated enrollment of patients in the ongoing initial clinical trial of its lead product candidate, the Neo-Urinary Conduit, which is being evaluated in bladder cancer patients requiring a urinary diversion following bladder removal.

14 Sep 2011

Efficient, economical molecule could speed evaluation of some anti-cancer treatments

Researchers from Boston College have developed a new class of small molecule receptors capable of detecting a lipid molecule that reveals the telltale signs of cellular death, particularly cancer cells targeted by anti-cancer drugs, the team reports in the current electronic edition of the Journal of the American Chemical Society.

14 Sep 2011

Intrauterine devices may protect against cervical cancer

Intrauterine devices (IUDs) may protect against cervical cancer. This is the conclusion of the broadest epidemiological study to date in which has participated the research group in Viruses and Cancer of IDIBELL, published at The Lancet Oncology.

14 Sep 2011

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

ViroPharma Incorporated and Halozyme Therapeutics announced today that ViroPharma has initiated an open-label, multi-dose Phase 2 study to evaluate the safety, and pharmacokinetics and pharmacodynamics of subcutaneous administration of Cinryze in combination with Halozyme's Enhanze technology, a proprietary drug delivery platform using Halozyme's recombinant human hyaluronidase enzyme, in subjects with hereditary angioedema.

14 Sep 2011

OBT, Seattle Genetics form strategic collaboration to discover novel ADCs for cancer

Seattle Genetics, Inc. and Oxford BioTherapeutics today announced that they have formed a strategic collaboration to jointly discover novel antibody-drug conjugates (ADCs) for cancer.

14 Sep 2011

New minimally invasive technique to diagnose early-stage ovarian cancer

By combining three previously unrelated imaging tools into one new device, a team of researchers from the University of Connecticut and the University of Southern California has proposed a new way to diagnose early-stage ovarian cancer in high-risk women through minimally invasive surgery. The new technique may be better than the current standard procedure of preemptively removing the ovaries.

14 Sep 2011

Acceleron commences ACE-536 Phase 1 clinical trial in anemia

Acceleron Pharma, Inc., a biopharmaceutical company developing protein therapeutics for cancer and orphan diseases today announced that it has initiated a Phase 1 clinical study of ACE-536.

14 Sep 2011

Henry Ford study identifies 23 microRNAs for laryngeal cancer

A Henry Ford Hospital study has identified 23 microRNAs for laryngeal cancer, a discovery that could yield new insight into what causes certain cells to grow and become cancerous tumors in the voice box.

14 Sep 2011

Combining cell biology and molecular genetics for single-cell research

Fluidigm Corporation has announced a collaboration with BD Biosciences, a segment of BD (Becton, Dickinson and Company), to co-host a public seminar series on the isolation and analysis of single cells. Entitled 'A Powerful Technique for Single-Cell Analysis', the public seminar series will showcase cell isolation using the BD FACSAria™ III Cell Sorter and analysis using the Fluidigm BioMark™ HD System.

13 Sep 2011

Fathers and family men low on testosterone: Study

A new study shows that men who spend time with their children have lower levels of testosterone than single guys. The study shows that family men experience a biological shift that may awaken their nurturing side.

13 Sep 2011

IBM's Watson supercomputer and WellPoint working towards computerized access to records and diagnoses

IBM's Watson supercomputer and a leading health insurer WellPoint Inc. are working towards diagnosis of medical ailments and authorize treatments for its 34.2 million members. Wellpoint operates Blue Cross Blue Shield plans in 14 states, including New York and California.

13 Sep 2011

Cancer News and Research

Latest Cancer News and Research

Nanobiotix starts clinical trial of new cancer treatment for soft tissue sarcoma

University of Antioquia and IBM partner for Leishmaniasis research

Web-based tool can improve employment outcomes of breast cancer survivors

Curcumin suppresses cell signaling pathway that drives growth of head and neck cancer

Lignans lower risk of death in women with breast cancer

Health Canada approves Afinitor for treatment of brain tumours caused by TSC in children

Roundup: N.J. Governor opts not to cut Medicaid rolls; Seattle council mandates sick leave

Intrauterine devices may lower risk of cervical cancer among users, study shows

Spices boost broccoli's power to fight cancer

Tengion reinitiates enrollment in Neo-Urinary Conduit clinical trial for bladder cancer

Efficient, economical molecule could speed evaluation of some anti-cancer treatments

Intrauterine devices may protect against cervical cancer

ViroPharma initiates Cinryze Phase 2 subcutaneous trial in patients with HAE

OBT, Seattle Genetics form strategic collaboration to discover novel ADCs for cancer

New minimally invasive technique to diagnose early-stage ovarian cancer

Acceleron commences ACE-536 Phase 1 clinical trial in anemia

Henry Ford study identifies 23 microRNAs for laryngeal cancer

Combining cell biology and molecular genetics for single-cell research

Fathers and family men low on testosterone: Study

IBM's Watson supercomputer and WellPoint working towards computerized access to records and diagnoses

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in